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ABSTRACT 
 
Association between sleep parameters and metabolic syndrome among 
healthy middle-aged Koreans 
 
BACKGROUND: 
Sleep has been recognized as one of the important factors related to various health 
problems. Several studies have reported that sleep status affects the morbidity of 
metabolic syndrome; however, there are limited studies, particularly in Korea. Thus, the 
current study evaluates the association of sleep parameters including sleep duration, 
difficulty in sleep initiation, and obstructive sleep apnea (OSA) risk with metabolic 
syndrome in healthy middle-aged Koreans. 
 
METHODS:  
This study used data from 1,659 participants (588 of male and 1,071 of female) aged 30 
to 64 years enrolled in the Cardiovascular and Metabolic diseases Etiology Research 
Center (CMERC) study conducted between 2013 and 2014. Multiple logistic regression 
models were used to examine the associations between sleep parameters and metabolic 
syndrome. 
 
RESULTS: 
Male participants with short sleep duration exhibited 3.41 times higher odds (95% 
confidence interval (CI) 1.40-8.28) of having metabolic syndrome after adjusting for age, 
body mass index, smoking status, drinking status, physical activity, depression, and risk 
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of OSA. On the other hand, female participants with difficulty in sleep initiation for 1–4 
days/week were at higher risk for metabolic syndrome (adjusted odds ratio (OR) 1.75; 95% 
CI 1.06–2.89) than those without difficulty in sleep initiation. People with short sleep 
duration and difficulty in sleep initiation had a higher risk of metabolic syndrome 
(adjusted OR 4.94; 95% CI 1.05–23.21 in males, 2.23; 95% CI 1.01–4.94 in females) 
than those with intermediate sleep duration and no difficulty in sleep initiation. 
Corresponding OR for people with short sleep duration and no difficulty in sleep 
initiation was 3.34 (95% CI 1.15–9.67) in males, 1.36 (95% CI 0.50–3.72) in females. 
The high risk of OSA group exhibited an increased risk of abdominal obesity with an 
adjusted OR of 3.61 (95% CI 2.76–4.71) and high blood pressure with an OR of 2.39 (95% 
CI 1.82–3.14) compared to the low risk of OSA group. 
 
CONCLUSION:  
Our study suggested that short sleep duration and difficulty in sleep initiation are 
associated with metabolic syndrome among healthy middle-aged Koreans. The results of 
our study also imply that it is important to assess the quantitative and qualitative aspects 
of sleep. In addition, the high risk of OSA group was associated with components of 
abdominal obesity and high blood pressure. However, considering the indicators for 
determining the risk of OSA, including body mass index and diagnosed hypertension, 
caution is needed in interpretation.  
 
 
 
 
Keywords: sleep, metabolic syndrome, healthy, middle-aged, Korean
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I. INTRODUCTION 
 
1. Background 
 
Sleep has been recognized as one of the crucial factors influencing various health 
problems. With modernization, characterized by the widespread use of electricity, human 
sleep patterns have been changed. Modern life comes with an increased demand for high 
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performance at work, increased shift work, prolonged commuting times, and multiple 
leisure time activities (Centers for Disease and Prevention, 2011; Krueger &Friedman, 
2009; Schoenborn &Adams, 2010). Generally, the proper sleep duration is about 7 to 8 
hours in healthy adults (Ayas et al., 2003; Heslop et al., 2002). However, recently, sleep 
duration has decreased across the globe. The average self-reported sleep duration has 
decreased from over 8 hours in the 1960s to about 6.5 hours in 2012, with 20 to 30% of 
middle-aged Americans reporting a sleep duration of less than 6 hours (Centers for 
Disease and Prevention, 2011; Krueger &Friedman, 2009). Similar patterns have been 
reported in Asian populations (Shankar et al., 2008; Tamakoshi et al., 2004). According to 
the sixth Korea National Health and Nutrition Examination Survey (KNHANES-Ⅵ) 2013, 
the daily average sleep duration was 6.7 hours in Korean adults. About 15.3% of those 
who responded stated that their daily average sleep duration was less than 6 hours (Korea 
Centers for Disease Control and Prevention, 2013). Moreover, Koreans’ average sleep 
duration is the shortest among the Organization for Economic Cooperation and 
Development (OECD) countries (OECD, 2011). 
  Several studies have reported that sleep duration is associated with obesity, diabetes, 
hypertension, atherosclerosis, and cardiovascular diseases (Ayas et al., 2003; Gottlieb et 
al., 2006; Taheri et al., 2004; Wolff et al., 2008; Yaggi et al., 2006). Moreover, short and 
long sleep durations have been shown to be linked to an increased risk of metabolic 
syndrome (Hall et al., 2008;Stefani et al., 2013). As some contend that sleep assessments 
based only on duration are not enough, some studies have suggested that it is necessary to 
consider qualitative aspects to understand global sleep status (Doi et al., 2000; Kaneita et 
al., 2008). Actually, in recent years, accumulated evidence has shown that sleep 
parameters, including not only sleep duration but also sleep quality and sleep disorders, 
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are independently associated with an increased risk of metabolic syndrome (Hung et al., 
2013; Jennings et al., 2007; Lee et al., 2013; Sasanabe et al., 2006).  
Metabolic syndrome, which consists of a complex combination of abdominal obesity, 
hypertension, impaired glucose tolerance, and dyslipidemia, is a significant health 
problem around the world (Alberti et al., 2009; Ervin, 2009; Fernandez-Berges et al., 
2012). This medical disorder increases the morbidity and mortality of cardiovascular 
diseases and stroke by increasing the risk of atherosclerosis (Kadota et al., 2007; Nigam 
et al., 2006; Tillin et al., 2006). To decrease the mortality and morbidity of cardiovascular 
diseases and stroke, it is important to prevent and/or improve their risk factors, including 
metabolic syndrome. Though various factors affecting metabolic syndrome have been 
studied (Kastorini et al., 2011; Lakka &Laaksonen, 2007; Park et al., 2003), adequate 
sleep quality and quantity have been suggested to play important roles in the normal 
functioning of daily metabolic and hormonal processes and appetite regulation (Van 
Cauter et al., 2008). In prospective observational studies, disturbed sleep has been related 
to both diabetes and cardiovascular disease and their risk factors (Roost &Nilsson, 2002). 
In experimental studies, sleep deprivation has been found to lower glucose tolerance and 
thyrotropin concentration, raise evening cortisol concentrations, and increase activity of 
the sympathetic nervous system, suggesting a neuroendocrine profile that may be 
conducive to full metabolic syndrome (Spiegel et al., 1999). 
Obstructive sleep apnea (OSA) is characterized by repeated episodes of apnea and 
hypopnea during sleep. In addition, there is a growing body of evidence to support the 
belief that severe OSA is a risk factor for metabolic syndrome and cardiovascular 
diseases (Marshall et al., 2008; Somers et al., 2008; Young et al., 2008). 
However, particularly in Korea, there have been limited studies; thus, they have not 
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provided sufficient evidence of the relation between sleep parameters and traditional 
indicators of metabolic impairments. Moreover, research reported in Korea has either 
considered only sleep duration (Stefani et al., 2013) or considered sleep duration and 
quality separately with relatively small numbers of subjects (Lee et al., 2013). 
 
2. Objectives 
 
This study evaluates the relationship of each of the sleep parameters including sleep 
duration, difficulty in sleep initiation, and OSA risk with metabolic syndrome in healthy 
middle-aged Koreans. We evaluated the prevalence of metabolic syndrome in healthy 
middle-aged Koreans according to self-reported sleep duration, difficulty in sleep 
initiation, and OSA risk. Moreover, we considered the combined effect of sleep duration 
and difficulty in sleep initiation, which may influence each other, on metabolic syndrome. 
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II. METHODS 
 
1. Study population 
 
This study used data from the Cardiovascular and Metabolic diseases Etiology 
Research Center (CMERC) study, an ongoing community-based cohort study. Over the 
course of five years, the CMERC study plans to recruit more than 4,000 participants 
relatively healthy middle-aged adults from urban and rural areas of South Korea. The 
CMERC study enrolled 1,663 participants aged 30 to 64 years in the 2013 and 2014 
baseline examinations. 
For the current analysis, we excluded two participants who had a history of stroke or 
myocardial infarction and two participants lacking information on fasting glucose level 
and waist circumference. Finally, 1,659 participants (588 male and 1,071 female) were 
analyzed to determine the association between sleep and metabolic syndrome. The final 
sample for the analyses of this study is outlined in Figure 1. All participants provided 
written informed consent, and the Institutional Review Board of Severance Hospital, 
Yonsei University College of Medicine, approved the study protocol. 
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Figure 2. Flowchart of the selection of the final study population
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2. Measurements 
 
1) Assessment of sleep parameters 
To investigate the study subjects’ sleep duration, difficulty in sleep initiation, and OSA 
risk, we used self-report questionnaires. Sleep duration was assessed by self-reported 
responses to the question, “During the past year, how many hours have you usually slept 
each day (including naps)?” Responses were assigned to one of three subcategories: Short 
(≤5 hours), Intermediate (5–9 hours), Long (≥9 hours). Short or long sleep durations were 
defined according to the International Classification of Sleep Disorders definition (Ito 
&Inoue, 2015). Difficulty in sleep initiation was assessed by self-reported responses to 
the question, “Do you currently have a sleep initiation problem?” Responses were 
assigned to one of three subcategories: None, 1–4 days/week, 5+ days/week. To evaluate 
OSA risk, we used the Berlin Questionnaire, which includes three categories with ten 
questions: five questions related to snoring behaviors/witnessed apneas (Category 1), 
three about daytime sleepiness (Category 2), and two about the patient’s history of 
hypertension and/or obesity (Category 3). Subjects were considered to be at a high risk 
for OSA if they had at least two of the following conditions: (1) Two positive answers to 
Category 1 questions that indicated the presence of persistent snoring (more than 3 times 
a week) with snoring sufficiently loud to be heard in the next room and/or persistent 
apnea (more than 3 times a week or everyday); (2) daytime sleepiness defined as ever 
falling asleep while driving or as feeling tired or fatigued after sleep and feeling tired or 
fatigued during wake time at least 3 days a week (Category 2); and (3) presence of 
hypertension or obesity. Subjects who denied chronic symptoms or had chronic 
symptoms or signs in only one category were classified as being at a low risk for OSA. 
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2) Assessment of metabolic syndrome 
Metabolic syndrome was defined based on the National Cholesterol Education 
Program Adult Treatment Panel Ⅲ (NCEP-ATP Ⅲ) criteria. The presence of any three of 
the following five abnormalities constitutes a diagnosis of metabolic syndrome: (ⅰ) 
waist circumference > 90cm in males and >80 cm in females; (ⅱ) elevated triglycerides 
with fasting plasma triglycerides ≥150mg/dL; (ⅲ) low HDL cholesterol with fasting 
HDL cholesterol <40 mg/dL in males and <50 mg/dL in females; (ⅳ) elevated blood 
pressure with systolic blood pressure ≥130mmHg and/or diastolic blood pressure ≥85 
mmHg and/or the use of BP-lowering medication; (ⅴ) elevated fasting plasma glucose 
with fasting plasma glucose ≥100 mg/dL and/or a diagnosis diabetes and/or the use of 
anti-diabetes medication. 
Waist circumference was measured between the lower borders of the rib cage and iliac 
crest with a measuring tape (SECA-201; SECA, Hamburg, Germany). Blood pressure 
was measured three times at an interval of 2 minutes by an autonomic 
sphygmomanometer (Omron HEM-7080IC, Omron Healthcare Co., Ltd., Kyoto, Japan) 
on the right arm of the subject while sitting after taking at least five minutes of rest. The 
second and third measurements were averaged for analyses. Blood samples were 
collected from the antecubital vein after at least 8 hours of fasting. Enzymatic methods 
were applied to measure total cholesterol, HDL cholesterol, and triglyceride, and fasting 
blood glucose levels were measured by the colorimetry method with an Auto Analyzer 
(ADVIA 1800; Siemens Healthcare Diagnostic Inc., Deerfield, IL, USA). 
 
11 
 
3) Covariates 
Age, sex, body mass index, smoking status, drinking status, physical activity and 
depression were considered as covariates in the present analyses. Age and body mass 
index were analyzed as continuous variables. Sex was categorized as male versus female. 
Smoking status was categorized into three groups: non-smoker, former smoker, and 
current smoker. Drinking status was categorized into three groups: non-drinker, former 
drinker, and current drinker. To assess physical activity level, we used self-reported data 
about the number of minutes spent in vigorous and moderately intense activity and 
walking during the last 7 days. We initially calculated the Metabolic Equivalents (METs)-
minutes score by multiplying the number of minutes by 8 (vigorous), 4 (moderate), and 
3.3 (walking) (Ainsworth, et al. 2000). Then, according to the Global Physical Activity 
Questionnaire (GPAQ) analysis framework, physical activity levels could be classified 
into low, moderate, or high intensity (WHO, 2004). To define depression, we used a 
Korean version of the Beck Depression Inventory-Ⅱ (BDI-Ⅱ) that has been validated in 
Korea (Song et al., 2012). Depression was defined as a BDI-Ⅱ score of 22 points or more. 
This cutoff value reflects clinical levels of depression in the Korean version of the BDI-
Ⅱ with 94% sensitivity and 98% specificity (Seo &Park, 2015). Additionally, females 
were categorized by menopausal status. 
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3. Statistical analysis 
 
Student’s t-test and the chi square test were used to analyze the general characteristics 
of the study population by sex. Multiple logistic regression models were used to examine 
the independent associations between sleep parameters and metabolic syndrome. We fit 
logistic regression models to examine the relationship between sleep duration, difficulty 
in sleep initiation (respectively or as a combined exposure), and risk for sleep apnea. 
Overall, we applied the following serial models: age, sex-adjusted (Model 1); age, sex, 
body mass index, smoking status, drinking status, physical activity, depression-adjusted 
(Model 2); age, sex, body mass index, smoking status, drinking status, physical activity, 
depression, other sleep parameters-adjusted (Model 3). When stratifying by sex, the “sex” 
variable was excluded in all models. When analyzing females, menopausal status was 
additionally adjusted in Models 2 and 3. All analyses were performed using SAS version 
9.2 (SAS Institute, Inc. Cary, NC), and statistical significance was defined as a two-sided 
p-value < 0.05.
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III. RESULTS 
 
1. Characteristics of the study population 
 
Table 1 lists the general characteristics of the study population in overall, male, and 
female participants. Out of a total of 1,659 subjects, 588 (35.4%) were male. Overall, the 
subjects’ mean age was 49.1 ± 9.7 years, and the mean body mass index was 23.7 ± 
3.1kg/m². Manual workers were 16.2%, and non-manual workers were 51.2% of the total. 
Current smokers were 15.3%, and current drinkers were 66.1% of the total. The mean 
BDI-Ⅱ score was 10.1 ± 7.5, and those with depression were 8.5% of the total. Those 
performing high-intensity physical activity were 20.3%, and those performing moderate-
intensity physical activity were 25.5%. Those with short and long sleep durations were 
15.7% of the total (9.2% and 6.5%, respectively), and 27.7% of subjects had difficulty in 
sleep initiation. When divided by sex, both sexes showed significant differences in age, 
education level, occupation, marital status, smoking status, drinking status, BDI-Ⅱ score, 
depression, sleep duration, difficulty in sleep initiation, OSA risk, and metabolic 
syndrome components (p<0.05 for each). For body mass index, physical activity level did 
not differ in male and female subjects. 
While 10.6% of females had metabolic syndrome, 21.0% of males met the criteria for 
metabolic syndrome. Among female subjects, the mean age was 50.1 ± 9.3 years, 10.8% 
had short sleep duration, 7.0% had long sleep duration, 31.6% had difficulty in sleep 
initiation, and 10.2% had depression, all of which were significantly higher than those in 
male subjects. On the other hand, male subjects were more likely current 
14 
 
smokers/drinkers and had a higher risk of OSA than females.
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Table 1. General characteristics of study population Variables Total Male  Female p-value (n=1,659) (n=588) (n=1,071) Age (years) 49.1 ± 9.7 47.3 ± 10.3 50.1 ± 9.3 0.0019 Body mass index (kg/m²) 23.7 ± 3.1 24.6 ± 3.0 23.2 ± 3.0 0.7711 Education (n=1,658)    <.0001 Elementary or Middle school graduate 279 (16.8) 53 (9.0) 226 (21.1)  High school graduate 609 (36.7) 176 (29.9) 433 (40.5)  College or higher graduate 770 (46.4) 359 (61.1) 411 (38.4)  Occupation    <.0001 Not employed 541 (32.6) 42 (7.1) 499 (46.6)  Manual 269 (16.2) 135 (23.0) 134 (12.5)  Non-manual 849 (51.2) 411 (69.9) 438 (40.1)  Marital status    <.0001 Married 1,422 (85.7) 532 (90.5) 890 (83.1)  Unmarried 237 (14.3) 56 (9.5) 181 (16.9)  Smoking status    <.0001 Non-smoker 1,131 (68.2) 141 (24.0) 990 (92.4)  Ex-smoker 275 (16.6) 236 (40.1) 39 (3.6)  Current smoker 253 (15.3) 211 (35.9) 42 (3.9)  Drinking status    <.0001     Non-drinker 487 (29.4) 64 (10.9) 423 (39.5)      Ex-drinker 76 (4.6) 35 (6.0) 41 (3.8)  Current drinker 1,096 (66.1) 489 (83.2) 607 (56.7)  BDI-Ⅱ score 10.1 ± 7.5 8.7 ± 6.7 10.8 ± 7.8 <.0001 Depression (BDI-Ⅱ score ≥22) 141 (8.5) 32 (5.4) 109 (10.2) 0.0009 Physical activity level    0.1763 High intensity 332 (20.0) 130 (22.1) 202 (18.9)  Moderate intensity 423 (25.5) 138 (23.5) 285 (26.6)  Low intensity 904 (54.5) 320 (54.4) 584 (54.5)  Sleep duration    0.0020 
Short (≤ 5 hours) 152 (9.2) 36 (6.1) 116 (10.8)  Intermediate (5–9 hours) 1,400 (84.4) 520 (88.4) 880 (82.2)  
Long (≥9 hours) 107 (6.5) 32 (5.5) 75 (7.0)  Difficulty in sleep initiation    <.0001 None 1,201 (72.4) 469 (80.0) 732 (68.4)  1–4days/week 321 (19.4) 85 (14.5) 236 (22.0)  5+ days/week 137 (8.3) 34 (5.8) 103 (9.6)  Obstructive sleep apnea    <.0001 Low risk 1,247 (75.2) 378 (64.3) 869 (81.1)  High risk 412 (24.8) 210 (35.7) 202 (18.9)  Metabolic syndrome components     Abdominal obesity 384 (23.2) 172 (29.3) 212 (19.8) <.0001 TG≥150mg/dL 379 (22.9) 212 (36.1) 167 (15.6) <.0001 Low HDL-C 416 (25.1) 113 (19.2) 303 (25.0) <.0001 Blood pressure ≥ 130/85 mmHg 513 (30.9) 245 (41.7) 268 (25.0) <.0001 Fasting glucose ≥ 100 mg/dL 239 (15.1) 126 (21.4) 121 (11.3) <.0001 Number of metabolic syndrome components     0 630 (38.0) 166 (28.2) 464 (43.3) <.0001 
≥1 1,029 (62.0) 422 (71.8) 607 (56.7) <.0001 
≥2 528 (31.8) 243 (41.3) 285 (26.6) <.0001 
≥3 (Metabolic syndrome) 235 (14.2) 122 (20.7) 113 (10.6) <.0001 Data were expressed as means ± standard deviation and number (%) 
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2. Association between sleep duration and metabolic syndrome 
 
Table 2 shows the odds ratio (OR) and 95% confidence interval (CI) of sleep duration 
for metabolic syndrome in study subjects. The intermediate sleep duration (5–9hours) 
group was used as a reference category in the logistic regression model. Overall, the 
crude ORs of the short (≤5 hours) and long (≥9 hours) sleep duration groups for 
metabolic syndrome were 2.07 (95% CI 1.39–3.10) and 0.72 (95% CI 0.37–1.41), 
respectively. After adjusted for age, sex, body mass index, smoking status, drinking status, 
physical activity, depression, and OSA risk, ORs were 1.88 (95% CI 1.14–3.10) and 0.74 
(95% CI 0.34–1.60), respectively. After stratifying by sex, the association of long sleep 
duration with metabolic syndrome was not significant (adjusted OR 0.85; 95% CI 0.27–
2.71 for males, 0.67; 95% CI 0.23–1.95 for females). In males, short sleep duration was 
associated with an increased risk of metabolic syndrome with a crude OR of 2.93 (95% 
CI 1.46–5.88) and an adjusted OR of 3.41 (1.40–8.28) compared to intermediate sleep 
duration. In females, short sleep duration was associated with a 2.16 times higher (crude 
OR, 95% CI 1.29–3.62) risk of metabolic syndrome than intermediate sleep duration. 
However, after potential confounders (and menopausal status) were adjusted, the 
significance disappeared (adjusted OR; 1.44, 95% CI 0.77–2.71).
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Table 2. Association between sleep duration and metabolic syndrome 
Sleep duration No. of Study population No.(%) of metabolic syndrome Odds ratio (95% CI) Unadjusted Model 1 Model 2 Model 3 Total (n=1,659)       Short (≤5 hours) 152 37 (24.3) 2.07 (1.39-3.10) 2.34 (1.55-3.54) 1.95 (1.20-3.16) 1.88 (1.14-3.10) Intermediate (5–9 hours) 1,400 188 (13.4) 1.00  1.00  1.00  1.00  Long (≥9 hours) 107 10 (9.4) 0.72 (0.37-1.41) 0.68 (0.34-1.35) 0.66 (0.31-1.39) 0.74 (0.34-1.60)      Males (n=588)           Short (≤5 hours) 36 15 (41.7) 2.93 (1.46-5.88) 2.98 (1.47-6.02) 3.44 (1.44-8.22) 3.41 (1.40-8.28) Intermediate (5–9 hours) 520 102 (19.6) 1.00  1.00  1.00  1.00  Long (≥9 hours) 32 5 (15.6) 0.76 (0.29-2.02) 0.75 (0.28-2.01) 0.64 (0.21-1.95) 0.85 (0.27-2.71)      Females (n=1,071)           Short (≤5 hours) 116 22 (19.0) 2.16 (1.29-3.62) 1.86 (1.09-3.16) 1.44 (0.78-2.64) 1.44 (0.77-2.71) Intermediate (5–9 hours) 880 86 (9.8) 1.00  1.00  1.00  1.00  Long (≥9 hours) 75 5 (6.7) 0.66 (0.26-1.68) 0.80 (0.31-2.08) 0.71 (0.25-1.99) 0.67 (0.23-1.95) Model 1: Adjusted for age (Additionally adjusted for sex in total study population) Model 2: Model 1 + adjusted for body mass index, smoking status, drinking status, physical activity, depression (Additionally adjusted for menopausal status in females) Model 3: Model 2 + adjusted for obstructive sleep apnea risk  
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3. Association between difficulty in sleep initiation and metabolic 
syndrome 
 
Table 3 displays the OR and 95% CI of difficulty in sleep initiation for metabolic 
syndrome before and after adjustment for the other potential confounders in study 
subjects. The group without difficulty in sleep initiation was used as a reference category 
in the logistic regression model. Overall, those who had difficulty in sleep initiation 1–4 
days/week exhibited an increased risk of metabolic syndrome with a crude OR of 1.47 
(95% CI 1.05–2.05) and an adjusted OR of 1.62 (95% CI 1.09–2.41) compared to the 
group without difficulty in sleep initiation. Even though the risk of having metabolic 
syndrome was higher, a significant association did not exist (crude OR 1.44; 95% CI 
0.90–2.32, adjusted OR 1.59; 95% CI 0.88–2.87). In males, no values were significant. 
On the other hand, in females, those who had difficulty in sleep initiation 1–4 days/week 
revealed a 2.23 times higher (crude OR, 95% CI 1.44–3.46) risk for metabolic syndrome 
than those who did not have difficulty in sleep initiation. After adjusted for potential 
confounders, the OR was 1.75 (95% CI 1.06–2.89) and significant. In the group that had 
difficulty in sleep initiation 5 days or more/week, the crude OR was 2.30 (95% CI 1.28–
4.13) and significant, yet in the fully adjusted model (OR 1.88; 95% CI 0.71–2.96), the 
significance disappeared.  
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Table 3. Association between difficulty in sleep initiation and metabolic syndrome Difficulty in sleep initiation No. of study population No.(%) of metabolic syndrome Odds ratio (95% CI) Unadjusted Model 1 Model 2 Model 3 Total (n=1,659)       None 1,201 154 (12.8) 1.00  1.00  1.00  1.00  1–4days/week 321 57 (17.8) 1.47 (1.05-2.05) 1.65 (1.17-2.33) 1.64 (1.11-2.43) 1.62 (1.09-2.41) 5+days/week 137 24 (17.5) 1.44 (0.90-2.32) 1.56 (0.96-2.53) 1.86 (1.06-3.27) 1.59 (0.88-2.87)            Males (n=588)           None 469 96 (20.5) 1.00  1.00  1.00  1.00  1–4days/week 85 19 (22.4) 1.12 (0.64-1.95) 1.12 (0.64-1.97) 1.25 (0.63-2.45) 1.32 (0.66-2.62) 5+days/week 34 7 (20.6) 1.01 (0.43-2.38) 1.00 (0.42-2.38) 2.20 (0.74-6.50) 2.20 (0.70-6.94)            Females (n=1,071)           None 732 58 (7.9) 1.00  1.00  1.00  1.00  1–4days/week 236 38 (16.1) 2.23 (1.44-3.46) 1.95 (1.24-3.07) 1.81 (1.10-2.98) 1.75 (1.06-2.89) 5+days/week 103 17 (16.5) 2.30 (1.28-4.13) 1.86 (1.02-3.38) 1.92 (0.87-3.37) 1.88 (0.71-2.96) Model 1: Adjusted for age (Additionally adjusted for sex in total study population) Model 2: Model 1 + adjusted for body mass index, smoking status, drinking status, physical activity, depression (Additionally adjusted for menopausal status in females) Model 3: Model 2 + adjusted for obstructive sleep apnea risk  
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4. OR (95% CI) for metabolic syndrome with sleep duration and 
difficulty in sleep initiation 
 
 Table 4 shows results for the association between the combined effect of sleep 
duration/difficulty in sleep initiation and metabolic syndrome by logistic regression 
analysis. The combination of sleep duration and difficulty in sleep initiation was 
categorized into six groups as follows: (ⅰ) short sleep duration/with difficulty in sleep 
initiation, (ⅱ) short sleep duration/without difficulty in sleep initiation, (ⅲ) intermediate 
sleep duration/with difficulty in sleep initiation, (ⅳ) intermediate sleep duration/without 
difficulty in sleep initiation, (ⅴ) long sleep duration/with difficulty in sleep initiation, (ⅵ) 
long sleep duration/without difficulty in sleep initiation. Overall, people who had 
difficulty in sleep initiation had a higher risk of metabolic syndrome even if the sleep 
duration was the same as that of a person who did not have difficulty in sleep initiation. 
After stratifying by sex, the results were slightly different compared to analyzing the 
variables separately (Table 3). According to the result for the association between 
difficulty in sleep initiation and metabolic syndrome, the values were not significant at all 
even if the OR of the fully adjusted model was higher than that of the reference group. 
However, when the combined effect of sleep duration and difficulty in sleep initiation 
was examined, the short sleep/with difficulty group revealed a 4.94 times higher (adjusted 
OR; 95% CI 1.05–23.21) risk of metabolic syndrome than the intermediate sleep/without 
difficulty group. This value was higher than the result of the short sleep/without difficulty 
group (adjusted OR 3.34; 95% CI 1.15–9.67). Results of other groups (intermediate 
sleep/with difficulty group, long sleep/with difficulty group, long sleep/without difficulty 
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group) were not significant. In females, the results for the association between sleep 
duration and metabolic syndrome were not significant after adjusted for potential 
confounders (Table 4). However, when the combined effect of sleep duration and 
difficulty in sleep initiation was examined, the crude and fully adjusted ORs of the short 
sleep/with difficulty group were 3.39 (95% CI 1.75–6.57) and 2.23 (95% CI 1.01–4.94), 
respectively. The intermediate sleep/with difficulty group had a higher risk of metabolic 
syndrome than the intermediate sleep/without difficulty group (crude OR 2.34; 95% CI 
1.49–3.68, adjusted OR 1.84; 95% CI 1.09–3.09). The results of the short sleep/without 
difficulty and long sleep/without or with difficulty groups were not significant at all.
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Table 4. Odds ratio (95% CI) for metabolic syndrome with sleep duration and difficulty in sleep initiation Group No. of Study population No.(%) of metabolic syndrome Odds ratio (95% CI) Unadjusted Model 1 Model 2 Model 3 Total (n=1,659)       Short sleep / Difficulty (+) 76 18 (23.7) 2.24 (1.28-3.92) 2.78 (1.55-4.97) 2.58 (1.32-5.02) 2.50 (1.27-4.94) Short sleep / Difficulty (-) 76 19 (25.0) 2.40 (1.39-4.17) 2.69 (1.53-4.73) 2.12 (1.06-4.22) 2.07 (1.03-4.15) Intermediate sleep / Difficulty (+) 357 61 (17.1) 1.49 (1.07-2.07) 1.66 (1.18-2.34) 1.78 (1.20-2.64) 1.80 (1.21-2.68) Intermediate sleep / Difficulty (-) 1,043 127 (12.2) 1.00  1.00  1.00  1.00  Long sleep / Difficulty (+) 25 2 (8.0) 0.63 (0.15-2.69) 0.66 (0.15-2.91) 0.52 (0.11-2.50) 0.60 (0.42-2.43) Long sleep / Difficulty (-) 82 8 (9.8) 0.78 (0.37-1.66) 0.82 (0.38-1.78) 0.89 (0.38-2.08) 1.01 (0.42-2.43)            Males (n=588)           Short sleep / Difficulty (+) 10 4 (40.0) 2.77 (0.77-10.06) 2.88 (0.79-10.50) 3.99 (0.88-18.03) 4.94 (1.05-23.21) Short sleep / Difficulty (-) 26 11 (42.3) 3.05 (1.35-6.89) 3.09 (1.35-7.04) 3.62 (1.26-10.35) 3.34 (1.15-9.67) Intermediate sleep / Difficulty (+) 102 21 (20.6) 1.08 (0.63-1.85) 1.08 (0.63-1.85) 1.42 (0.73-2.75) 1.49 (0.76-2.91) Intermediate sleep / Difficulty (-) 418 81 (19.4) 1.00  1.00  1.00  1.00  Long sleep / Difficulty (+) 7 1 (14.3) 0.69 (0.08-5.84) 0.70 (0.08-5.92) 0.81 (0.08-8.59) 1.15 (0.11-12.44) Long sleep / Difficulty (-) 25 4 (16.0) 0.79 (0.27-2.37) 0.78 (0.26-2.34) 0.65 (0.19-2.27) 0.88 (0.24-3.18)            Females (n=1,071)           Short sleep / Difficulty (+) 66 14 (21.2) 3.39 (1.75-6.57) 2.70 (1.37-5.32) 2.32 (1.08-5.00) 2.23 (1.01-4.94) Short sleep / Difficulty (-) 50 8 (16.0) 2.40 (1.06-5.41) 2.06 (0.89-4.73) 1.31 (0.48-3.57) 1.36 (0.50-3.72) Intermediate sleep / Difficulty (+) 255 40 (15.7) 2.34 (1.49-3.68) 2.02 (1.27-3.20) 1.90 (1.14-3.17) 1.84 (1.09-3.09) Intermediate sleep / Difficulty (-) 625 46 (7.4) 1.00  1.00  1.00  1.00  Long sleep / Difficulty (+) 18 1 (5.6) 0.74 (0.10-5.69) 0.71 (0.09-5.54) 0.39 (0.20-2.48) 0.36 (0.04-3.23) Long sleep / Difficulty (-) 57 4 (7.0) 0.95 (0.33-2.74) 1.18 (0.40-3.49) 1.32 (0.40-4.30) 1.27 (0.38-4.24) Model 1: Adjusted for age (Additionally adjusted for sex in total study population) Model 2: Model 1 + adjusted for body mass index, smoking status, drinking status, physical activity, depression (Additionally adjusted for menopausal status in females) Model 3: Model 2 + adjusted for obstructive sleep apnea risk  
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5. Association between OSA and metabolic syndrome components 
 
In the case of OSA risk, those who had a history of diagnosed hypertension were 
included in Category 3 of the Berlin Questionnaire and had the “high blood pressure” 
component of metabolic syndrome, so we examined the association with each component 
of metabolic syndrome rather than with the metabolic syndrome prevalence of the 
subjects (Table 5). In all metabolic syndrome components, the high risk of OSA group 
revealed a higher risk of each metabolic syndrome component than the low risk of OSA 
group. However, after adjusting potential confounders including other metabolic 
syndrome components, the significance disappeared in the elevated triglyceride and 
elevated fasting glucose components. In the case of the low HDL-cholesterol component, 
only in females, the high risk of OSA group exhibited a 1.49 times higher (95% CI 1.03–
2.16) risk than the low risk of OSA group. Compared to the low risk of OSA group, the 
high-risk group had a 3.61 times higher (95% CI 2.76–4.71) risk of abdominal obesity 
after adjusting the multiple potential confounders. Even when males and females were 
viewed separately, the results were similar. The adjusted OR was 3.99 (95% CI 2.66–5.99) 
in males and 3.54 (95% CI 2.45–5.10) in females, and all results were statistically 
significant. Moreover, the high risk of OSA group revealed a 2.39 times higher (adjusted 
OR; 95% CI 1.82–3.14) risk for the high blood pressure component in overall participants, 
1.53 times higher (adjusted OR; 95% CI 1.01–2.31) risk in male participants, and 3.36 
times higher (adjusted OR; 95% CI 2.32–4.87) risk in female participants.  
24 
 
Table 5. Association between obstructive sleep apnea and metabolic syndrome components A) Abdominal obesity 
Obstructive sleep apnea risk Odds ratio (95% CI) Unadjusted Adjusted for age, sex, smoking status, drinking status, physical activity, depression, sleep duration, triglyceride, HDL-cholesterol, fasting glucose level Total (n=1,659)   Low risk 1.00  1.00  High risk 4.65 (3.63-5.95) 3.61 (2.76-4.71) 
      Males (n=588)     Low risk 1.00  1.00  High risk 4.47 (3.07-6.52) 3.99 (2.66-5.99) 
      Females (n=1,071)     Low risk 1.00  1.00  High risk 4.37 (3.12-6.12) 3.54 (2.45-5.10) 
      B) Triglyceride≥150mg/dL 
Obstructive sleep apnea risk Odds ratio (95% CI) Unadjusted Adjusted for age, sex, smoking status, drinking status, physical activity, depression, sleep duration, waist circumference, HDL-cholesterol, fasting glucose level Total (n=1,659)     Low risk 1.00  1.00  High risk 2.75 (2.15-3.52) 1.30 (0.96-1.75) 
      Males (n=588)     Low risk 1.00  1.00  High risk 2.30 (1.62-3.27) 1.32 (0.86-2.02) 
      Females (n=1,071)     Low risk 1.00  1.00  High risk 2.36 (1.63-3.41) 1.26 (0.81-1.96) 
      C) Low HDL-cholesterol 
Obstructive sleep apnea risk Odds ratio (95% CI) Unadjusted Adjusted for age, sex, smoking status, drinking status, physical activity, depression, sleep duration, waist circumference, triglyceride, fasting glucose level Total (n=1,659)     Low risk 1.00  1.00  High risk 1.87 (1.46-2.38) 1.33 (0.99-1.78) 
      Males (n=588)     Low risk 1.00  1.00  High risk 1.87 (1.24-2.84) 1.09 (0.65-1.83) 
      Females (n=1,071)     Low risk 1.00  1.00  High risk 2.35 (1.71-3.23) 1.49 (1.03-2.16) 
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Table 5. Association between obstructive sleep apnea and metabolic syndrome components 
(continued) D) Blood pressure ≥ 130/85 mmHg or use of anti-hypertensive medication 
Obstructive sleep apnea risk 
Odds ratio (95% CI) 
Unadjusted Adjusted for age, sex, smoking status, drinking status, physical activity, depression, sleep duration, waist circumference, triglyceride, HDL-cholesterol, fasting glucose level Total (n=1,659)     Low risk 1.00  1.00  High risk 3.29 (2.60-4.15) 2.39 (1.82-3.14) 
      Males (n=588)     Low risk 1.00  1.00  High risk 2.11 (1.49-2.97) 1.53 (1.01-2.31) 
      Females (n=1,071)     Low risk 1.00  1.00  High risk 3.98 (2.88-5.50) 3.36 (2.32-4.87) 
      E) Fasting glucose ≥ 100 mg/dL or history of diabetes diagnosis or use of anti-diabetes medication 
Obstructive sleep apnea risk Odds ratio (95% CI) Unadjusted Adjusted for age, sex, smoking status, drinking status, physical activity, depression, sleep duration, waist circumference, triglyceride, HDL-cholesterol level Total (n=1,659)     Low risk 1.00  1.00  High risk 2.25 (1.70-2.93) 1.24 (0.90-1.72) 
      Males (n=588)     Low risk 1.00  1.00  High risk 2.14 (1.44-3.20) 1.49 (0.94-2.35) 
      Females (n=1,071)     Low risk 1.00  1.00  High risk 1.82 (1.18-2.80) 1.00 (0.62-1.62) 
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IV. DISCUSSION 
 
In previous studies, assessment of sleep duration has been mainly used to evaluate the 
status of sleep. However, measuring sleep duration only is insufficient for understanding 
global sleep status, which consists of not only sleep duration but also sleep quality and 
sleep disorders. These sleep-related factors include quantitative and qualitative variables, 
which has made sleep status difficult to understand. Considering both aspects, we 
evaluated sleep duration (quantitative variable) and difficulty in sleep initiation and OSA 
risk (qualitative variables). To evaluate these two aspects of sleep parameters, we used 
self-reported questionnaire. For the 1,659 participating Korean adults aged 30 to 64 years, 
we examined the associations of metabolic syndrome with sleep duration and difficulty in 
sleep initiation separately and the combined effect of the two variables. We also 
examined the relationship between OSA risk and each of the metabolic syndrome 
components. When sleep duration and difficulty in sleep initiation were examined 
separately, our results showed a significant association of metabolic syndrome with short 
sleep duration, particularly in male participants, and with difficulty in sleep initiation in 
female participants. However, when the combined effect of sleep duration and difficulty 
in sleep initiation was examined in males and females, it revealed that it is associated 
with metabolic syndrome.  
So far, few studies have reported on the association between metabolic syndrome and 
global sleep status, especially in Korea. Thus, the current study provides good evidence 
of the relationship between sleep parameters and metabolic syndrome. As far as we know, 
there are no studies on the association between the combined effect of sleep 
duration/difficulty in sleep initiation and metabolic syndrome, so our results are 
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meaningful, as they consider the relationship between quantitative and qualitative aspects 
of sleep parameters together and metabolic syndrome.  
Previous studies have produced diverse results on the association between sleep 
parameters and metabolic syndrome, possibly due to the diversity in the characteristics of 
the study subjects or the considered variables, including sleep-related parameters.  
Many previous studies have reported that short and long sleep durations related with 
metabolic syndrome generally present a U-shaped curvilinear pattern (Hall et al., 2008; 
Stefani et al., 2013). In the present study, concerning only sleep duration, the short sleep 
duration (≤ 5 hours) showed a higher prevalence of metabolic syndrome, particularly in 
male participants. In our study, long sleep duration seems to be shown rather negative 
association with metabolic syndrome, even if the value was not significant at all. Our 
study population was relatively healthy adults without history of cardiovascular and 
cerebrovascular diseases. Moreover, concerning the age of study subjects, our study 
subjects were middle-aged (mean age was 49.1 years), and 93% of male subjects were 
currently working. In addition, only 6.5% of the total subjects reported a long sleep 
duration. Considering that, sleep duration may be influenced by age and working status, 
and this difference between the studies could explain the different results. Therefore, the 
present study was focused on middle-aged Koreans who mainly contribute to productivity. 
Thus, we need to expand the age of participants to clarify the relationship between long 
sleep duration and metabolic syndrome. 
Concerning difficulty in sleep initiation, the prevalence of metabolic syndrome was 
presently higher in the group that had difficulty in sleep initiation than in the group that 
did not have difficulty (Table 3). According to previous studies, as sleep quality 
decreases, metabolic syndrome becomes more common, with elevated insulin resistance 
resulting from central adiposity being involved in this relationship (Hung et al., 2013; 
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Jennings et al., 2007; Lee et al., 2013; Sasanabe et al., 2006). In previous studies, aspects 
of sleep quality have been assessed by diverse way. Many studies have been assessed 
sleep status by Pittsburgh Sleep Quality Index (PSQI) which is reliable and valid 
questionnaire for evaluating the aspects of sleep quality in Korea (Sohn et al., 2012). 
However, our analysis did not use PSQI to evaluate sleep quality, because we used 
different form of questionnaire from the PSQI. Consequently, compared to previous 
studies, the meaning of sleep quality was different, so we examined the difficulty in sleep 
initiation by self-reported data. This study indicated that those who had difficulty in sleep 
initiation had a higher metabolic syndrome risk, especially females, even if they slept 
long enough. However, concerning the combined effect of sleep duration and difficulty in 
sleep initiation, our study suggested that considering sleep duration and difficulty 
together is necessary when evaluating the association with metabolic syndrome risk. 
Females who had difficulty in sleep initiation and a short sleep duration had a higher risk 
of metabolic syndrome. A similar pattern was observed in male participants, as people 
who had difficulty in sleep initiation had a higher risk of metabolic syndrome, even if 
they belonged to the same sleep duration group.  
Concerning the OSA risk, the high-risk group showed a higher prevalence of metabolic 
syndrome components of abdominal obesity and high blood pressure compared to the 
other groups (Table 5). Sasanabe et al. (2006) reported that both males and females with 
OSA (Apneal-Hypopnea Index [AHI] ≥/hour) had higher ORs for metabolic syndrome 
compared with controls (OR 3.47 and 6.59; 95% CI 1.84–6.53 and 1.47–29.38, 
respectively). After the adjustment for age and body mass index, the adjusted OR of the 
AHI ≥ 15 /hour group was 2.08 (1.41–3.06) in males and 2.24 (0.84–5.99) in females. 
Lee et al. (2013) reported results similar to ours in their study, which examined the 
relationship between OSA risk and metabolic syndrome in 301 Koreans. The results of 
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their study showed a higher prevalence of the abdominal obesity component and a 
number of metabolic syndrome components in the high risk of OSA group than the low 
risk of OSA group. According to previous studies, OSA seems to affect the pathway of 
metabolites in various ways. However, considering the indicators for determining the risk 
of OSA according to the Berlin Questionnaire, including body mass index and 
hypertension, caution is needed in the interpretation of the relationship between OSA and 
metabolic syndrome. 
The mechanism of the relationship between sleep disorders and metabolic syndrome 
has not been clarified due to a lack of confirming evidence. Sleep rhythm is regulated by 
the hypothalamus. Sleep disorders activate the hypothalamic-pituitary-adrenal axis (HPA), 
enhancing the secretion of stress hormones, such as cortisol and catecholamine. These 
excess secretions finally lead to an increased risk of metabolic syndrome. The 
sympathomimetic state induced by poor sleep quality reduces leptin levels and elevates 
ghrelin levels, which is also related with obesity. Furthermore, it enhances stress hormone 
secretion (Rangaraj &Knutson, 2015).  
Our study has some advantages. We were able to consider the comprehensive 
relationships taking lifestyles and depression into account. Moreover, we were able to 
evaluate not only sleep duration but also the comprehensive sleep status, including 
difficulty in sleep initiation and risk of OSA. In addition, this is the first study evaluating 
the combined effect of sleep duration and difficulty in sleep initiation on metabolic 
syndrome. However, our study has some limitations. First, this study was designed as a 
cross-sectional analysis. Thus, the causal relationship between sleep parameters and 
metabolic syndrome could not be investigated. Second, our study population was not 
representative of the entire middle-aged Korean population. The subjects could be 
slightly different from the general population, as only participants in the CMERC study 
30 
 
were included in this study. The prevalence of metabolic syndrome was lower in this 
study (14.1%) than in the KNHANES-Ⅵ (2013) (26.4%) which is nationally 
representative survey of the non-institutionalized civilian population, and is annually 
carried out by the Korea Centers for Disease Control and Prevention (KCDC). Although 
directly comparing the result of the KNHANES-Ⅵ (2013) is inappropriate because of 
differences in the age structure and sex ratio, our study population seems to be relatively 
healthier than the general population. Third, we evaluated sleep parameters using self-
report questionnaires, which may be inaccurate because of the possibility of the answers 
differing from the truth. Although the accelerometer is used as an objective index for 
evaluating the current sleep state, it also has a limitation. It is not reflecting average 
physical activity level as it only measures 7 days. Combining the accelerometer and self-
report questionnaires may have led to a different result.
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V. CONCLUSION 
 
Our cross-sectional study using data from the CMERC study 2013 and 2014 suggested 
that sleep parameters including sleep duration, difficulty in sleep initiation, and OSA risk 
were associated with metabolic syndrome among healthy middle-aged Koreans. 
In male participants, short sleep duration (≤ 5 hours/day) was associated with an 
increased risk of metabolic syndrome. On the other hand, females who had difficulty in 
sleep initiation were at a higher risk of metabolic syndrome. However, when the 
relationship between the combined effect of sleep duration/difficulty in sleep initiation 
and metabolic syndrome was examined, the results showed that short sleep duration and 
difficulty in sleep initiation were both related to metabolic syndrome in both male and 
female participants. This may imply that quantitative and qualitative aspects of sleep 
should be considered together when evaluating sleep status. Moreover, when we 
examined the relationship of OSA risk and metabolic syndrome components, the high 
risk of OSA group was found to be associated with abdominal obesity by measuring waist 
circumference and blood pressure. However, considering the indicators for determining 
the risk of OSA, including body mass index and diagnosed hypertension, caution is 
needed in the interpretation.  
Further studies are warranted to generalize our results. If future studies establish the 
causality between sleep and metabolic syndrome, and affirm that various sleep 
parameters are risk factors for metabolic syndrome, appropriate sleep management may 
help prevent metabolic syndrome development. 
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Korean Abstract 
 
건강한 한국 중년 인구에서 수면과 대사증후군과의 
관련성 
 
 
지도교수 김현창 
 
연세대학교 대학원 보건학과 
김나래 
 
 
연구 배경 및 목적: 수면 상태는 여러 건강 문제와도 밀접한 연관성이 있다고 
보고되어 왔다.여러 선행연구들을 통해 수면 상태와 대사증후군과의 관련성이 
연구되어왔지만, 수면 시간이나 수면의 질, 그리고 동반되는 수면 장애들까지 
복합적으로 고려한 연구들은 아직 부족한 상태이다. 이에, 본 연구에서는 
건강한 한국 중년 인구를 대상으로 수면 시간, 수면유도장애 그리고 
수면무호흡증과 대사증후군과의 독립적인 관련성을 연구하고자 한다. 
 
연구 방법: 본 연구는 지역사회기반 전향적 코호트인 Cardiovascular and 
Metabolic diseases Etiology Research Center (CMERC) study의 일부로, 
2013년과 2014년에 연구 참여에 동의하고 기반조사를 마친 30세에서 
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64세의 성인을 대상으로 시행되었다.  
수면 시간과 수면유도장애의 경험 여부 그리고 수면무호흡증의 위험과 
대사증후군과의 독립적인 관련성을 보기 위해 단순회귀분석과 다중회귀분석을 
시행하였으며, 혼란변수로는 성, 연령, 체질량지수, 흡연상태, 음주상태, 
신체활동량, 우울증 여부 등을 보정하였다.  
 
연구 결과: 수면 시간과 수면유도장애 경험 여부를 각각 대사증후군과의 
관련성을 보았을 때, 남자에서는 짧은 수면시간이 대사증후군과 통계적으로 
유의한 관련성이 있었지만 (Odds Ratio (OR) 3.41; 95% CI 1.40-8.28) 
여자에서는 통계적으로 유의한 관련성을 보이지 않았다. 여자에서는 주 1-
4일 수면유도장애를 겪는 군이 대사증후군과 독립적인 관련성이 있었고 (OR 
1.75; 95% CI 1.06-2.89), 남자에서는 통계적으로 유의한 관련성을 보이지 
않았다. 수면시간과 수면유도장애의 경험 여부를 결합하여 그 결과를 보았을 
때, 남자와 여자에서 모두 수면 시간이 짧으면서 수면 유도 장애를 겪고 있는 
군에서 대사증후군일 오즈비가 높게 나타났다 (각각 OR 4.94; 95% CI 1.05-
23.21, OR 2.23; 95% CI 1.01-4.94). 그리고 수면무호흡증과 대사증후군 
각각의 지표들과의 관련성을 보았을 때, 남자와 여자 모두에서 수면무호흡증 
고위험군은 복부 비만 지표 (각각 OR 3.99; 95% CI 2.66-5.99, OR 3.54 95% 
CI 2.45-5.10)와 고혈압 지표 (각각 OR 1.53; 95% CI 1.01-2.31, OR 3.36; 
95% CI 2.43-4.87)에서 독립적인 관련성이 있었으며, 고밀도지질단백질 
콜레스테롤의 경우 여자에서만 통계적으로 유의한 관련성을 보였다 (OR 1.49; 
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95% CI 1.03-2.16) 
 
결론: 본 연구에서는 지역사회 거주 한국 중년 인구에서는 짧은 수면시간과 
수면 유도 장애의 경험이 모두 대사증후군과 양의 관련성을 보였다. 이는 
수면의 양적인 측면과 질적인 측면을 함께 고려하는 것이 필요하다는 것을 
시사한다. 또한 남자와 여자 모두에서 수면무호흡증의 고위험군에 속하는 
사람들이 복부 비만이나 높은 혈압의 지표와 독립적인 관련성이 있었지만, 
수면무호흡증의 위험도를 선별하는 지표에 체질량지수와 고혈압 진단여부가 
포함되어 있다는 것을 고려하여볼 때, 해석에 주의가 필요할 것으로 사료된다.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
핵심어: 수면, 대사증후군, 한국, 중년 
